DNAStar and Michigan University Sign Lasergene Site License Agreement
News Apr 25, 2006
Sources at DNAStar indicated that it is likely that thousands of researchers at the University of Michigan will use Lasergene based on this agreement.
Lasergene is a comprehensive suite of tools for molecular biologists and geneticists used primarily in the analysis of DNA and protein sequences.
It has been sold in over 65 countries worldwide and the University of Michigan joins a growing list of organizations that are making Lasergene the standard sequence analysis software program for their organization.
"We are thrilled that an institution with the University of Michigan’s reputation chose Lasergene as their standard tool for sequence analysis," stated Fred Blattner, DNAStar’s co-founder, CEO and President.
"The University of Michigan is a world renowned research institution and they have made a clear choice to standardize their platform on the product that many consider to be the gold standard against which other molecular biology desktop software products are measured."
Tom Schwei, DNAStar’s Vice President and General Manager added, "We have recently put a renewed emphasis on site license arrangements with major research institutes."
"With a site license, individual scientists continue to obtain all the benefits of the tool at their desktop."
"In addition, centralized IT managers have easy administration and coordination of needs within the entire institute."
"As more organizations begin to use core facilities and centralize their IT infrastructure, we expect to see an increasing number of arrangements like this in the future."
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE